GCMI CEO Tiffany Wilson to present at U.S. Food & Drug Administration Public Meeting on Pediatric Medical Device Development

On August 14, 2018, GCMI CEO Tiffany Wilson will present before an open public meeting hosted by the U.S. FDA on Pediatric Medical Device Development in Silver Spring, MD. This meeting provides a discussion about strategies to enhance the medical device ecosystem to cultivate development and innovation of devices that serve the unique needs of…

Evaluating or Ready to Engage an Industry Leading Preclinical CRO? Connect with T3 Labs at TCT 2018, Booth 334!

The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 21-25, 2018 in San Diego, California. GCMI and T3 Labs will be attending as an exhibitor at TCT again this year. Our booth number is 334.  We’re excited to spend…

Industry leading speakers including GCMI, JPMorgan, AdvaMed, Halyard and more announced for SEMDA 2018

Earlier this week, the Southeastern Medical Device Association announced several industry leading plenary and keynote speakers set for next month’s 2018 SEMDA Annual Medtech Conference in Greenville, South Carolina. Representing GCMI, and its Design and Development line of service, our Product Development Director, Mike Fisher will serve on a panel led by Paul Snyder, VP of…